Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus

Ali RM 1 , Degenhardt R , Zambahari R , Tresukosol D , Ahmad WA , Kamar Hb Show all authors , Kui-Hian S , Ong TK , bin Ismail O , bin Elis S , Udychalerm W , Ackermann H , Boxberger M , Unverdorben M

Affiliations 

  • 1 National Heart Institute, Kuala Lumpur, Malaysia
EuroIntervention, 2011 May;7 Suppl K:K83-92.
PMID: 22027736 DOI: 10.4244/EIJV7SKA15

Abstract

Coronary lesions in diabetics (DM) are associated with a high recurrence following percutaneous coronary intervention (PCI), even after drug-eluting stent (DES) deployment. Encouraging clinical data of the drug-eluting balloon catheter (DEB) SeQuent Please warrant its investigation in these patients.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications